Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
29
Number of overlapping holdings
14.4%
% of IBB's 219 holdings also in CANC
64.4%
% of CANC's 45 holdings also in IBB
Overlap by Weight
Sector Drift (IBB minus CANC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in IBB |
Weight in CANC |
Overlap | |
---|---|---|---|---|
REGENERON PHARMACEUTICALS | 8.2% | 5.6% | 5.6% | |
GILEAD SCIENCES INC | 8.2% | 2.9% | 2.9% | |
ILLUMINA INC | 2.0% | 3.5% | 2.0% | |
MODERNA, INC. | 3.7% | 2.0% | 2.0% | |
ARGENX SE ADR | 2.0% | 2.9% | 2.0% |
Position Highlights (Non-Overlapping Exposures)
IBB Overweight Relative to CANC
AMGEN INC | 8.7% | |
VERTEX PHARMACEUTICALS INC | 8.3% | |
GILEAD SCIENCES INC | 5.4% | |
IQVIA HOLDINGS INC | 4.4% | |
BIOGEN IDEC INC | 3.0% | |
METTLER-TOLEDO INTERNATIONAL | 2.7% | |
REGENERON PHARMACEUTICALS | 2.7% | |
ALNYLAM PHARMACEUTICALS INC | 2.0% | |
BIONTECH SE SPONSORED ADR | 1.9% | |
WATERS CORP | 1.9% |
IBB Underweight Relative to CANC
MERCK & CO. INC. | -5.6% | |
DAIICHI SANKYO CO LTD | -4.0% | |
ASTRAZENECA PLC | -3.8% | |
NOVARTIS AG | -3.7% | |
EXACT SCIENCES CORP | -3.1% | |
CHUGAI PHARMACEUTICAL CO LTD | -2.7% | |
CELLDEX THERAPEUTICS INC | -2.6% | |
REVOLUTION MEDICINES, INC. | -2.6% | |
BRISTOL-MYERS SQUIBB CO | -2.5% | |
BLUEPRINT MEDICINES CORP. | -2.0% |